Santhera Pharmaceuticals (S3F0.STU) Q2 2026 Earnings

28AprConfirmed
Q3 2025
Q2 2026
-3.24
-2.45
-1.65
-0.85

Details

Expected EPS
N/A
Actual EPS
-0.8505079059399999
Surprise EPS
-0.85
Surprise Percent
+∞%

Description

Santhera Pharmaceuticals (S3F0.STU) has reported earnings of -0.8505079059399999 per share for Q2 2026.

0 Comments

Share your thoughts